Cardax, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 10/30/2017
Contact Info
  • 2800 Woodlawn Drive
  • Suite 129
  • Honolulu, HI 96822

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001544238
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2006
Employees 10 a/o Sep 30, 2017
Company Officers/Contacts
David G. Watumull CEO, President
David M. Watumull COO, Asst. Treasurer, Asst. Secretary
John B. Russell CFO, Treasurer
Richard M. Morris Secretary
Company Directors
George W. Bickerstaff, III Chairman
Michele Galen
Terence A. Kelly, Ph.D.
David G. Watumull
Service Providers
Accounting/Auditing Firm
114 West 47th Street, 19th Floor
Suite 1900
New York, NY, 10036
United States
Securities Counsel
Herrick Feinstein LLP
Two Park Ave
New York, NY, 10016
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=Koffee Korner Inc until 2-2014
CDXI Security Details
Share Structure
Market Value1 $20,169,600 a/o Jan 19, 2018
Authorized Shares 400,000,000 a/o Jan 02, 2018
Outstanding Shares 122,240,002 a/o Jan 02, 2018
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 3,345,914 a/o Mar 12, 2015
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 450 a/o Sep 30, 2017
Short Selling Data
Short Interest 9,500 (0%)
Dec 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security